Metabolic Alterations Mediated by STAT3 Promotes Drug Persistence in CML

By exploring the role of STAT3 in altering metabolism, researchers provided insight into identifying potential therapeutic targets for eliminating tyrosine kinase inhibitor-persistent leukemic stem cells.